STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,741,147 | -13.7% | 188,640 | +20.0% | 0.37% | +33.6% |
| Q3 2022 | $2,018,000 | -74.3% | 157,200 | -32.6% | 0.28% | -47.3% |
| Q2 2021 | $7,847,000 | +34.0% | 233,135 | +54.7% | 0.53% | +18.3% |
| Q1 2021 | $5,854,000 | +838.1% | 150,729 | +453.1% | 0.45% | +475.6% |
| Q1 2020 | $624,000 | -91.4% | 27,254 | -89.4% | 0.08% | -87.0% |
| Q4 2019 | $7,261,000 | -1.7% | 256,380 | -26.0% | 0.60% | -47.6% |
| Q3 2019 | $7,384,000 | -24.0% | 346,380 | -1.3% | 1.14% | -14.1% |
| Q2 2019 | $9,718,000 | – | 350,944 | – | 1.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |